Increase in Blood–Brain Barrier Permeability is Modulated by Tissue Kallikrein via Activation of Bradykinin B1 and B2 Receptor-Mediated Signaling

References

• Dong Y, Qu J, Zhang Z, Wang C, Dong Q. Human urinary kallidinogenase in treating acute ischemic stroke patients: analyses of pooled data from a randomized double-blind placebo-controlled phase IIb and Phase III clinical trial. Neurol Res. 2020;42(4):286–290. doi:10.1080/01616412.2020.1711648
   PubMed Web of Science ®Google Scholar
• Hillmeister P, Persson PB. The Kallikrein-kinin system. Acta Physiol. 2012;206(4):215–219. doi:10.1111/apha.12007
   PubMed Web of Science ®Google Scholar
• Chao J, Bledsoe G, Yin H, Chao L. The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction. Biol Chem. 2006;387(6):665–675. doi:10.1515/BC.2006.085
   PubMed Web of Science ®Google Scholar
• Zhang Q, Ding H, Yan J, et al. Plasma tissue kallikrein level is negatively associated with incident and recurrent stroke: a multicenter case-control study in China. Ann Neurol. 2011;70(2):265–273. doi:10.1002/ana.22404
   PubMed Web of Science ®Google Scholar
• Han L, Li J, Chen Y, et al. Human urinary kallidinogenase promotes angiogenesis and cerebral perfusion in experimental stroke. PLoS One. 2015;10(7):e0134543. doi:10.1371/journal.pone.0134543
   PubMed Web of Science ®Google Scholar
• Li J, Chen Y, Zhang X, Zhang B, Zhang M, Xu Y. Human urinary kallidinogenase improves outcome of stroke patients by shortening mean transit time of perfusion magnetic resonance imaging. J Stroke Cerebrovasc Dis. 2015;24(8):1730–1737. doi:10.1016/j.jstrokecerebrovasdis.2015.03.032
   PubMed Web of Science ®Google Scholar
• Chen ZB, Huang DQ, Niu FN, Zhang X, Li EG, Xu Y. Human urinary kallidinogenase suppresses cerebral inflammation in experimental stroke and downregulates nuclear factor-kappaB. J Cereb Blood Flow Metab. 2010;30(7):1356–1365. doi:10.1038/jcbfm.2010.19
   PubMed Web of Science ®Google Scholar
• Shi Y, Zhang L, Pu H, et al. Rapid endothelial cytoskeletal reorganization enables early blood-brain barrier disruption and long-term ischaemic reperfusion brain injury. Nat Commun. 2016;7:10523. doi:10.1038/ncomms10523
   PubMed Web of Science ®Google Scholar
• Xia CY, Zhang Z, Xue YX, Wang P, Liu YH. Mechanisms of the increase in the permeability of the blood-tumor barrier obtained by combining low-frequency ultrasound irradiation with small-dose bradykinin. J Neurooncol. 2009;94(1):41–50. doi:10.1007/s11060-009-9812-9
   PubMed Web of Science ®Google Scholar
• Zhang H, Gu YT, Xue YX. Bradykinin-induced blood-brain tumor barrier permeability increase is mediated by adenosine 5ʹ-triphosphate-sensitive potassium channel. Brain Res. 2007;1144:33–41. doi:10.1016/j.brainres.2007.01.133
   PubMed Web of Science ®Google Scholar
• Kuhr F, Lowry J, Zhang Y, Brovkovych V, Skidgel RA. Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors. Neuropeptides. 2010;44(2):145–154. doi:10.1016/j.npep.2009.12.004
   PubMed Web of Science ®Google Scholar
• Bartus RT, Elliott PJ, Dean RL, et al. Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7. Exp Neurol. 1996;142(1):14–28. doi:10.1006/exnr.1996.0175
   PubMed Web of Science ®Google Scholar
• Schilling L, Wahl M. Mediators of cerebral edema. Adv Exp Med Biol. 1999;474:123–141.
   PubMed Web of Science ®Google Scholar
• Raslan F, Schwarz T, Meuth SG, et al. Inhibition of bradykinin receptor B1 protects mice from focal brain injury by reducing blood-brain barrier leakage and inflammation. J Cereb Blood Flow Metab. 2010;30(8):1477–1486. doi:10.1038/jcbfm.2010.28
   PubMed Web of Science ®Google Scholar
• Gobel K, Pankratz S, Schneider-Hohendorf T, et al. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking. J Autoimmun. 2011;36(2):106–114. doi:10.1016/j.jaut.2010.11.004
   PubMed Web of Science ®Google Scholar
• Tang M, Liu P, Li X, Wang JW, Zhu XC, He FP. Protective action of B1R antagonist against cerebral ischemia-reperfusion injury through suppressing miR-200c expression of microglia-derived microvesicles. Neurol Res. 2017;39(7):612–620. doi:10.1080/01616412.2016.1275096
   PubMed Web of Science ®Google Scholar
• Wei Z, Lyu Y, Yang X, Chen X, Zhong P, Wu D. Therapeutic values of human urinary kallidinogenase on cerebrovascular diseases. Front Neurol. 2018;9:403. doi:10.3389/fneur.2018.00403
   PubMed Web of Science ®Google Scholar
• Kumar M, Tyagi N, Moshal KS, et al. GABAA receptor agonist mitigates homocysteine-induced cerebrovascular remodeling in knockout mice. Brain Res. 2008;1221:147–153. doi:10.1016/j.brainres.2008.04.021
   PubMed Web of Science ®Google Scholar
• Gurses C, Ekizoglu O, Orhan N, et al. Levetiracetam decreases the seizure activity and blood-brain barrier permeability in pentylenetetrazole-kindled rats with cortical dysplasia. Brain Res. 2009;1281:71–83. doi:10.1016/j.brainres.2009.05.033
   PubMed Web of Science ®Google Scholar
• Guo C, Wang H, Liang W, et al. Bilobalide reversibly modulates blood-brain barrier permeability through promoting adenosine A1 receptor-mediated phosphorylation of actin-binding proteins. Biochem Biophys Res Commun. 2020;526(4):1077–1084. doi:10.1016/j.bbrc.2020.03.186
   PubMed Web of Science ®Google Scholar
• Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis. 2010;37(1):13–25. doi:10.1016/j.nbd.2009.07.030
   PubMed Web of Science ®Google Scholar
• Vernon H, Clark K, Bressler JP. In vitro models to study the blood brain barrier. Methods Mol Biol. 2011;758:153–168.
   PubMedGoogle Scholar
• Weinstein DE. Isolation and purification of primary rodent astrocytes. Curr Protoc Neurosci. 2001;1:3–5.
   Google Scholar
• Sobczak M, Dargatz J, Chrzanowska-Wodnicka M. Isolation and culture of pulmonary endothelial cells from neonatal mice. J Vis Exp. 2010;14:e2316.
   Google Scholar
• Aneja RK, Alcamo AM, Cummings J, et al. Lack of benefit on brain edema, blood-brain barrier permeability, or cognitive outcome in global inducible high mobility group box 1 knockout mice despite tissue sparing after experimental traumatic brain injury. J Neurotrauma. 2019;36(2):360–369. doi:10.1089/neu.2018.5664
   PubMed Web of Science ®Google Scholar
• Daneman R, Barres BA. The blood-brain barrier–lessons from moody flies. Cell. 2005;123(1):9–12. doi:10.1016/j.cell.2005.09.017
   PubMed Web of Science ®Google Scholar
• Ben-Zvi A, Lacoste B, Kur E, et al. Mfsd2a is critical for the formation and function of the blood-brain barrier. Nature. 2014;509(7501):507–511. doi:10.1038/nature13324
   PubMed Web of Science ®Google Scholar
• Szulcek R, Bogaard HJ, van Nieuw Amerongen GP. Electric cell-substrate impedance sensing for the quantification of endothelial proliferation, barrier function, and motility. J Vis Exp. 2014;85:51300.
   Google Scholar
• Ke Y, Oskolkova OV, Sarich N, et al. Effects of prostaglandin lipid mediators on agonist-induced lung endothelial permeability and inflammation. Am J Physiol Lung Cell Mol Physiol. 2017;313(4):L710–L721. doi:10.1152/ajplung.00519.2016
   PubMed Web of Science ®Google Scholar
• Haileselassie B, Joshi AU, Minhas PS, Mukherjee R, Andreasson KI, Mochly-Rosen D. Mitochondrial dysfunction mediated through dynamin-related protein 1 (Drp1) propagates impairment in blood brain barrier in septic encephalopathy. J Neuroinflammation. 2020;17(1):36. doi:10.1186/s12974-019-1689-8
   PubMed Web of Science ®Google Scholar
• Fujimoto T, Morofuji Y, Kovac A, et al. Pitavastatin ameliorates lipopolysaccharide-induced blood-brain barrier dysfunction. Biomedicines. 2021;9(7):837. doi:10.3390/biomedicines9070837
   PubMed Web of Science ®Google Scholar
• Fanning AS, Jameson BJ, Jesaitis LA, Anderson JM. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem. 1998;273(45):29745–29753. doi:10.1074/jbc.273.45.29745
   PubMed Web of Science ®Google Scholar
• Silva LS, Pinheiro AS, Teixeira DE, et al. Kinins released by erythrocytic stages of Plasmodium falciparum enhance adhesion of infected erythrocytes to endothelial cells and increase blood brain barrier permeability via activation of bradykinin receptors. Front Med. 2019;6:75. doi:10.3389/fmed.2019.00075
   Web of Science ®Google Scholar
• Miao J, Deng F, Zhang Y, Xie HY, Feng JC. Exogenous human urinary kallidinogenase increases cerebral blood flow in patients with acute ischemic stroke. Neurosciences. 2016;21(2):126–130. doi:10.17712/nsj.2016.2.20150581
   PubMed Web of Science ®Google Scholar
• Abdullahi W, Tripathi D, Ronaldson PT. Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection. Am J Physiol Cell Physiol. 2018;315(3):C343–C356. doi:10.1152/ajpcell.00095.2018
   PubMed Web of Science ®Google Scholar
• Sikpa D, Whittingstall L, Savard M, et al. Pharmacological modulation of blood-brain barrier permeability by kinin analogs in normal and pathologic conditions. Pharmaceuticals. 2020;13(10):279. doi:10.3390/ph13100279
   Web of Science ®Google Scholar
• Liu Y, Hashizume K, Chen Z, et al. Correlation between bradykinin-induced blood-tumor barrier permeability and B2 receptor expression in experimental brain tumors. Neurol Res. 2001;23(4):379–387. doi:10.1179/016164101101198596
   PubMed Web of Science ®Google Scholar
• Regoli D, Gobeil F. Kinins and peptide receptors. Biol Chem. 2016;397(4):297–304. doi:10.1515/hsz-2015-0240
   PubMed Web of Science ®Google Scholar
• Nico B, Quondamatteo F, Herken R, et al. Developmental expression of ZO-1 antigen in the mouse blood-brain barrier. Brain Res Dev Brain Res. 1999;114(2):161–169. doi:10.1016/S0165-3806(99)00008-5
   PubMedGoogle Scholar
• Chao J, Shen B, Gao L, Xia CF, Bledsoe G, Chao L. Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing. Biol Chem. 2010;391(4):345–355. doi:10.1515/bc.2010.042
   PubMed Web of Science ®Google Scholar
• Shi R, Yuan K, Hu B, et al. Tissue kallikrein alleviates cerebral ischemia-reperfusion injury by activating the B2R-ERK1/2-CREB-Bcl-2 signaling pathway in diabetic rats. Oxid Med Cell Longev. 2016;2016:1843201. doi:10.1155/2016/1843201
   PubMed Web of Science ®Google Scholar
• Sang H, Qiu Z, Cai J, et al. Early increased bradykinin 1 receptor contributes to hemorrhagic transformation after ischemic stroke in type 1 diabetic rats. Transl Stroke Res. 2017;8(6):597–611. doi:10.1007/s12975-017-0552-4
   PubMed Web of Science ®Google Scholar
• Wagner S, Kalb P, Lukosava M, Hilgenfeldt U, Schwaninger M. Activation of the tissue kallikrein-kinin system in stroke. J Neurol Sci. 2002;202(1–2):75–76. doi:10.1016/S0022-510X(02)00208-3
   PubMed Web of Science ®Google Scholar
• Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 2008;57(2):178–201. doi:10.1016/j.neuron.2008.01.003
   PubMed Web of Science ®Google Scholar
• Nguyen LN, Ma D, Shui G, et al. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature. 2014;509(7501):503–506. doi:10.1038/nature13241
   PubMed Web of Science ®Google Scholar
• Chen H, Konofagou EE. The size of blood-brain barrier opening induced by focused ultrasound is dictated by the acoustic pressure. J Cereb Blood Flow Metab. 2014;34(7):1197–1204. doi:10.1038/jcbfm.2014.71
   PubMed Web of Science ®Google Scholar
• Patel JP, Frey BN. Disruption in the blood-brain barrier: the missing link between brain and body inflammation in bipolar disorder? Neural Plast. 2015;2015:708306. doi:10.1155/2015/708306
   PubMed Web of Science ®Google Scholar